Infant, Extremely Premature

• 

  Subject Areas on Research

  • A Rare Association of Non-Compaction of the Ventricular Myocardium, and Non-Immune Hydrops Fetalis. 
  • A paradigm shift in the treatment of extreme prematurity: the artificial placenta. 
  • A predictive model for extubation readiness in extremely preterm infants. 
  • Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study. 
  • Admission Temperature and Associated Mortality and Morbidity among Moderately and Extremely Preterm Infants. 
  • An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. 
  • Antecedents of Obesity Among Children Born Extremely Preterm. 
  • Assessment of an Updated Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford Network. 
  • Association between Policy Changes for Oxygen Saturation Alarm Settings and Neonatal Morbidity and Mortality in Infants Born Very Preterm. 
  • Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. 
  • Behavior Profiles at 2 Years for Children Born Extremely Preterm with Bronchopulmonary Dysplasia. 
  • Behavioral Deficits at 18-22 Months of Age Are Associated with Early Cerebellar Injury and Cognitive and Language Performance in Children Born Extremely Preterm. 
  • Behavioral Problems and Socioemotional Competence at 18 to 22 Months of Extremely Premature Children. 
  • Behavioral problems are associated with cognitive and language scores in toddlers born extremely preterm. 
  • Between-hospital variation in treatment and outcomes in extremely preterm infants. 
  • Causes and timing of death in extremely premature infants from 2000 through 2011. 
  • Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus. 
  • Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age. 
  • Delay in retinal photoreceptor development in very preterm compared to term infants. 
  • Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants. 
  • Developmental Outcomes of Extremely Preterm Infants with a Need for Child Protective Services Supervision. 
  • Developmental outcomes of extremely preterm infants born to adolescent mothers. 
  • Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension. 
  • Disrupted Maturation of the Microbiota and Metabolome among Extremely Preterm Infants with Postnatal Growth Failure. 
  • Diuretic exposure in premature infants from 1997 to 2011. 
  • Does preterm period sleep development predict early childhood growth trajectories? 
  • Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants. 
  • ECLS for preemies: the artificial placenta. 
  • Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. 
  • Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature. 
  • Factors associated with feeding progression in extremely preterm infants. 
  • Genetic variants associated with patent ductus arteriosus in extremely preterm infants. 
  • Genetic variation in dopamine neurotransmission and motor development of infants born extremely-low-birthweight. 
  • Genome-wide association study of sepsis in extremely premature infants. 
  • Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. 
  • Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis. 
  • Impact of Early-Onset Sepsis and Antibiotic Use on Death or Survival with Neurodevelopmental Impairment at 2 Years of Age among Extremely Preterm Infants. 
  • Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability. 
  • Improving the Process of Enteral Nutrition Preparation With Milk Technicians: Perceptions of Cost, Time, and Quality. 
  • In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. 
  • Integrating neurocritical care approaches into neonatology: should all infants be treated equitably? 
  • Late-onset Sepsis in Extremely Premature Infants: 2000-2011. 
  • Left vocal cord paralysis after patent ductus arteriosus ligation: A systematic review. 
  • Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation. 
  • Neurocognitive and Health Correlates of Overweight and Obesity among Ten-Year-Old Children Born Extremely Preterm. 
  • Neurodevelopmental Impairment Among Extremely Preterm Infants in the Neonatal Research Network. 
  • Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage. 
  • Neurodevelopmental outcomes among extremely premature infants with linear growth restriction. 
  • Neurologic Outcome After Prematurity: Perspectives of Parents and Clinicians. 
  • Optimizing protein intake in premature infants: a neonatal quality improvement project. 
  • Outcome of Preterm Infants with Transient Cystic Periventricular Leukomalacia on Serial Cranial Imaging Up to Term Equivalent Age. 
  • Outcome of extremely preterm infants (<1,000 g) with congenital heart defects from the National Institute of Child Health and Human Development Neonatal Research Network. 
  • Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g. 
  • PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi. 
  • PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT). 
  • Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. 
  • Patterns of phlebotomy blood loss and transfusions in extremely low birth weight infants. 
  • Pharmacokinetics of ticarcillin-clavulanate in premature infants. 
  • Prolonged duration of early antibiotic therapy in extremely premature infants. 
  • Racial/Ethnic Disparities Among Extremely Preterm Infants in the United States From 2002 to 2016. 
  • Rifampin use and safety in hospitalized infants. 
  • Serum tocopherol levels in very preterm infants after a single dose of vitamin E at birth. 
  • Should Neonatologists Give Opinions Withdrawing Life-sustaining Treatment? 
  • Sleep-Wake States and Feeding Progression in Preterm Infants. 
  • Survival and Neurodevelopmental Outcomes among Periviable Infants. 
  • The Association of Hydrocortisone Dosage on Mortality in Infants Born Extremely Premature. 
  • Thinner Retinal Nerve Fiber Layer in Very Preterm Versus Term Infants and Relationship to Brain Anatomy and Neurodevelopment. 
  • Timing for the Introduction of Cycled Light for Extremely Preterm Infants: A Randomized Controlled Trial. 
  • Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. 
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. 
  • Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. 
  • Use of antihypotensive therapies in extremely preterm infants. 
  • Use of prophylactic antibiotics in women with previable prelabor rupture of membranes. 
  • Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis. 
  • Visualizing Macular Microvasculature Anomalies in 2 Infants With Treated Retinopathy of Prematurity.